Pillars of protection absent as Italy opens

Problems epitomise challenges many countries face

Italy’s virus reopening was supposed to be accompanied by a series of measures to limit infections in the one-time epicentre of Europe’s pandemic. They included the distribution of millions of inexpensive surgical masks to pharmacies nationwide, a pilot project of 150,000 antibody tests and, eventually, the roll-out of a contacttracing app.

None of these is in place as Italy experiments with its second week of loosening restrictions and looks ahead to Monday’s reopening of shops and, in some regions, bars and restaurants.

Italy’s commissioner for the emergency, Domenico Arcuri, went on the defensive on Tuesday to respond to mounting criticism of his Phase II rollout.

He insisted “Italians know well what to do” to protect themselves, even if they don’t have the tests, masks, contact-tracing or other measures that public health authorities deemed necessary for Italy to reopen in safety.

“Sometimes I make mistakes for which I expect criticism and, if necessary, reprimand, from Italians,” Arcuri said. But he directed the blame at others and repeated that he was working solely in the public’s interest.

Italy is by no means alone in emerging from lockdown without all its infection-prevention pillars in place.

But Italy’s problems epitomise the challenges many countries face as they seek to balance economic and health care needs while reassuring terrified citizens with promises that perhaps were overly optimistic.

France’s pledge to “protect, test and trace” all those who come into contact with a coronavirus patient was dealt a setback on Monday when

the constitutional court threw out part of its new virus law. The court objected to the contact-tracing language and ordered the government to take extreme care in protecting privacy.

The law, which took effect Tuesday, calls for teams of healthcare workers to trace the contacts of Covid-19 patients and share that data on a government server, with or without the patients’ consent.

French President Emmanuel Macron has also repeatedly pledged that France would be able to test up to 700,000 people a week. The national health authority told the Associated Press on Tuesday that France was averaging 200,000-270,000 tests a week.

Britain, which has Europe’s highest official death toll at more than 32,700,

has ramped up its testing from 5000 a day in March to close to 100,000 a day now. But it abandoned contact tracing after the virus’ spread overwhelmed its capacity. A contacttracing app is in trial stages and 18,000 people are being recruited to do the tracing legwork now.

Spain which, like Italy, was among the hardest-hit countries early on, is still ironing out protocols for contact tracing and has no immediate plans to roll out an app.

Germany, which has prided itself on its comparatively low death rate, has engaged more than 10,000 people in contact tracing. An app is planned but is still weeks away. Turkey, meanwhile, has credited its army of contact tracers for its success in slowing the virus’ spread. About 5850 teams contacted and tested close to 470,000 people suspected of being infected. Italy abandoned any concerted effort at contact tracing when its north got overwhelmed in late February. But health care officials say contact tracing, as well as testing, masks and social distancing, remain key to further reopening.

Italy’s mask problem began when Arcuri, the emergency commissioner, fixed a set price — 0.5 euro plus tax — for surgical masks that Italy only began producing domestically in recent weeks.

Producers baulked at the low price and two distributors that had promised to get 12 million masks to pharmacies ended up not having them ready. Another 19 million made it to supermarkets, but the pharmacy shelves remained bare.

Deputy Health Minister Pierpaolo Sileri acknowledged the mask distribution plan had become a “mess” after three-quarters of the 12 million masks hadn’t been certified.

Arcuri also promised that Italy would distribute antibody tests to labs on May 4 for a pilot project of 150,000 people. Testing still hasn’t begun.

Arcuri insisted his team has “done our part” by selecting the type of test and said delays were because of a review by the government’s privacy guarantor. He also said another 5 million virus test kits were being distributed to Italian regional health authorities to help boost capacity and isolate new possible clusters.

Italy was stymied during the outbreak by testing limitations, and ended up only testing those who went to the hospital or were showing strong symptoms. It has increased capacity and now leads Europe in per-capita testing, with more than 2.5 million tests to date.

But regional officials say they can’t do more tests because they didn’t receive the extra reagent necessary to process the results.

Arcuri said reagent is running low worldwide, and he is now asking domestic makers to boost production “in the coming weeks and months”.